Prosonix Limited clinical trials
Acquired by NIOX Group plc, Jun 15, 2015 · source ↗
The registry lists 1 studies whose lead sponsor is Prosonix Limited. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 30, 2016.
- 1study on the registry
- 0open to participants now
Before and after it joined NIOX Group plc
- First submitted before Prosonix Limited became part of NIOX Group plc
- 1
- First submitted after Prosonix Limited became part of NIOX Group plc
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Prosonix Limited’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.
Studies, none open
- 0 open · 1
All 1 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed1100%
Over the years
- 113
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Prosonix Limited1 study
Something wrong with this grouping? Tell us on the NIOX Group plc page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All NIOX Group plc studies →
- Dose Ranging Study of Glycopyrronium Bromide in Patients With Moderate or Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT01703624Phase 2
Sponsor listed in the registry: Prosonix Limited · First submitted before Prosonix Limited became part of NIOX Group plc